A Study of Sovilnesib in Subjects With Ovarian Cancer

Conditions: High Grade Serous Adenocarcinoma of Ovary; Fallopian Tube Cancer; Primary Peritoneal Carcinoma; Chromosomal Instability Interventions: Drug: Sovilnesib Sponsors: Volastra Therapeutics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials